A research team led by Prof. Xu Zhiheng from the Institute of Genetics and Developmental Biology of the Chinese Academy of ...

Aviceda Therapeutics ("the Company" or "Aviceda"), a clinical-stage biotechnology company developing innovative therapies for retinal diseases, today announced topline results from its SIGLEC Phase 2b ...

Astera Labs is upgraded from Sell to Hold after a 31% correction, as valuation excesses have largely normalized. Learn more ...